Biotech Values

[Mufaso]

Lilly's Mounjaro if approved for weight loss, could become the annual biggest selling drug of all time

Annual sales of tirzepatide could hit a record $48 billion, according to an estimate from Bank of America analyst Geoff Meacham. Another Wall Street analyst, Colin Bristow at UBS, estimated the drug would reach $25 billion in annual sales — a figure that would still surpass the record $20.7 billion set by AbbVie’s rheumatoid arthritis drug Humira in 2021.

https://www.nbcnews.com/health/health-news/weight-loss-drug-affordability-rcna60422

Getting lots of media attention. An analyst on CNBC was just talking about how the weight loss market has really come on in the last year. He expected NOVO with OZEMPIC/WEGOVY going against LLY Mounjaro to become very interesting. He also commented that there was a drug from Viking (VKTX) that could become a player. He didn't mention any other company.